Home›Companies›Healthcare›Mizar Therapeutics

Mizar Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 9, 2025·Suggest an edit

About Mizar Therapeutics

Mizar Therapeutics is a private company based in Woods Hole, Massachusetts, incorporated in 2022 in Delaware. It has reported $518,616 raised in one offering on Form D since June 2025. Its chief executive is Joel Smith.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 9, 2025Jun 9, 2025$518,616of $718K target6$86,436EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Mizar Therapeutics's Form D filed Jun 9, 2025.

PM
Paul Maddox
Executive officer and director
JS
Joel Smith
CEO and director

Sources

  1. SECMizar Therapeutics, Inc. filing history